Salvetti Massimo, Paini Anna, Bertacchini Fabio, Stassaldi Deborah, Aggiusti Carlo, Agabiti Rosei Claudia, Bassetti Davide, Agabiti-Rosei Enrico, Muiesan Maria Lorenza
Department of Clinical and Experimental Sciences, University of Brescia, 2a Medicina ASST Spedali Civili di Brescia, Italy and Società Italiana dell'Ipertensione Arteriosa.
Department of Clinical and Experimental Sciences, University of Brescia, 2a Medicina ASST Spedali Civili di Brescia, Italy and Società Italiana dell'Ipertensione Arteriosa.
Pharmacol Res. 2018 Aug;134:193-199. doi: 10.1016/j.phrs.2018.06.026. Epub 2018 Jun 26.
The reduction of echocardiographic left ventricular (LV) mass and the change toward a less concentric geometry during antihypertensive treatment are independently associated with a better prognosis. Blood pressure-lowering treatment may reduce cardiac hypertrophy, although different effect on changes of LV mass have been reported among antihypertensive drug classes, while changes in echocardiographic evaluated LV geometry have not been systemically evaluated. It is not yet clear whether antihypertensive drugs may influence LV geometry. Our aim was to compare the effects of diuretics (D), beta-blockers (BB), calcium channel blockers (CCB), angiotensin-converting enzyme inhibitors (ACE-I), and angiotensin receptor blockers (ARBS) on relative wall thickness (RWT) in patients with hypertension on the basis of prospective, randomized comparative studies.
MEDLINE, and the ISI Web of Sciences were searched for randomized clinical trials evaluating LV mass and geometry at baseline and end follow-up. We have performed a pooled pairwise comparisons of the effect of the 5 major drug classes on relative wall thickness changes, and of each drug class versus other classes statistically combined.
We selected 53 publications involving 7684 patients. A significant correlation was observed between percent changes from baseline to end of treatment in LV mass and those in systolic BP (r = 0.44, p < 0.001). Reduction of LV mass was significantly greater with CCB than with BB (P < 0.02) without other significant differences between drug classes. Percent changes in RWT were related to percent changes in LV mass/LVmass index (r = 0.68, p = 0.016) and of SBP (r = 0.64 p < 0.033). RWT decreased during treatment with all classes of drugs, except the combination of BB and D; the decrease of RWT was less with diuretics and sympatholytic drugs.
In studies evaluating the effect of different classes of antihypertensive drugs on LV mass, the reduction of relative wall thickness seems to be less during treatment with diuretics.
在抗高血压治疗期间,超声心动图测量的左心室(LV)质量的降低以及向不太同心的几何形状的转变与更好的预后独立相关。降压治疗可能会减轻心脏肥大,尽管不同类别的抗高血压药物对左心室质量变化的影响已有报道,但超声心动图评估的左心室几何形状的变化尚未得到系统评估。目前尚不清楚抗高血压药物是否会影响左心室几何形状。我们的目的是在前瞻性、随机对照研究的基础上,比较利尿剂(D)、β受体阻滞剂(BB)、钙通道阻滞剂(CCB)、血管紧张素转换酶抑制剂(ACE-I)和血管紧张素受体阻滞剂(ARBs)对高血压患者相对壁厚度(RWT)的影响。
检索MEDLINE和科学引文索引(ISI)网络数据库,查找在基线和随访结束时评估左心室质量和几何形状的随机临床试验。我们对5大类药物对相对壁厚度变化的影响进行了汇总的成对比较,并对每种药物类别与其他类别进行了统计学合并比较。
我们选择了53篇涉及7684例患者的出版物。从治疗基线到结束时左心室质量的百分比变化与收缩压的百分比变化之间存在显著相关性(r = 0.44,p < 0.001)。钙通道阻滞剂使左心室质量的降低显著大于β受体阻滞剂(P < 0.02),药物类别之间无其他显著差异。相对壁厚度的百分比变化与左心室质量/左心室质量指数的百分比变化(r = 0.68,p = 0.016)和收缩压的百分比变化(r = 0.64,p < 0.033)相关。除β受体阻滞剂和利尿剂联合使用外,所有药物治疗期间相对壁厚度均降低;利尿剂和抗交感神经药物使相对壁厚度的降低较少。
在评估不同类别的抗高血压药物对左心室质量影响的研究中,利尿剂治疗期间相对壁厚度的降低似乎较少。